Instalab
logoInstalab

Estradiol (E2)

Explore how your body clears estrogen through a full-day urine collection.
4.9 (3,899 reviews)
Tested by Genova Diagnostics
Physician-reviewed results
Results in 21–24 business days
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped directly to you
Get results
Explained with clear next steps, no medical jargon

Should you take a Estradiol (E2) test?

This test is most useful if any of these apply to you.

Going Through Perimenopause
You want an exploratory look at estrogen excretion, while using symptoms and cycle history to understand the transition.
Concerned About Breast Cancer in Your Family
You want to understand estrogen research without treating this urine result as a cancer-risk score.
A Man Investigating Hormone Symptoms
You want context on urinary estrogen metabolism alongside the blood tests and examination used to assess your symptoms.
Curious About Estrogen Metabolism
You're considering an exploratory measurement and understand that changing the result hasn't been shown to improve health.

About Estradiol (E2)

A 24-hour urine collection gives a pooled view of estradiol excretion during that day. The result depends on hormone production, metabolism, and elimination. It isn't a direct measure of how much estrogen your body makes or an average of your blood estradiol level.

This test can add information about urinary estrogen excretion within a broader estrogen panel. Using it to predict disease, choose hormone doses, or measure the success of a prevention plan remains exploratory. Analytical accuracy and proven clinical usefulness are separate questions.

What the Urine Number Represents

Estradiol is the main estrogen during the reproductive years. Before menopause, the ovaries produce most circulating estradiol. Men and postmenopausal women also make it by converting testosterone and other precursor hormones in tissues such as fat. Aromatase is the enzyme responsible for this conversion.

Before estradiol leaves your body in urine, much of it is attached to chemical groups that make it easier to excrete. These attached forms are called conjugates. The urine assay releases estradiol from its conjugates before measuring it, so this result represents a different hormone fraction from routine blood estradiol.

This test uses liquid chromatography with tandem mass spectrometry, abbreviated LC-MS/MS. The method separates chemicals and identifies estradiol by its molecular properties. Results are reported in micrograms per gram of creatinine, written as mcg/g creatinine. Creatinine is a waste product generated largely by muscle. Dividing by urine creatinine helps account for urine dilution, but the reported value remains a ratio rather than an absolute amount excreted per day.

Blood and urine measurements are related, but they aren't interchangeable. A study comparing blood with first-morning urine found only moderate agreement for estradiol, with differences by sex and menopause status. That study used a different collection from this full-day test. Neither a urine concentration nor a urine estrogen ratio can be converted into a blood estradiol level.

Breast and Endometrial Cancer

Estrogen can stimulate the growth of breast tumors that carry estrogen receptors. Higher circulating estradiol is associated with greater breast cancer risk after menopause. Genetic studies also support a causal contribution to estrogen receptor positive breast cancer and endometrial cancer, particularly the endometrioid subtype. Those analyses estimated lifelong differences in blood estradiol; they didn't validate urinary estradiol as an individual cancer-risk test.

Studies of estrogen breakdown products have been less consistent. A pooled analysis of four cohorts using blood or urine found lower breast cancer risk with a greater proportion of certain breakdown products formed through 2-hydroxylation. This is one route the body uses to process estrogen. A later study using plasma from the Nurses' Health Study found associations that didn't match that pattern. Differences in specimens, measurements, and the proportions being compared matter.

The breakdown products in a urine panel can describe estrogen metabolism, but labeling a pathway as protective or harmful goes beyond what these studies establish. Your urine result doesn't provide a validated estimate of breast or uterine cancer risk. Family history, inherited risk variants, and established screening remain the basis of a prevention plan.

Heart and Metabolic Health

Blood studies have linked estradiol to cardiovascular outcomes, but the findings depend on who was studied and what was measured. In a cross-sectional study of 614 postmenopausal women, lower serum estradiol was associated with more calcium buildup in the abdominal aorta. Because hormone levels and artery calcification were assessed at the same time, the study couldn't establish cause and effect.

Who Was StudiedWhat Was MeasuredWhat Was Found
954 young and middle-aged men without cardiovascular disease, cancer, or diabetes at enrollmentSerum estradiol measured with an antibody-based assayLower estradiol was associated with more cardiovascular deaths during follow-up.
Men in a pooled analysis of prospective cohortsBlood estradiol measured with mass spectrometryVery low estradiol was associated with higher all-cause mortality.
Men and women in the UK BiobankA calculated free estradiol index based on serum estradiol and SHBGA higher index was associated with lower heart failure risk in men but higher risk in premenopausal women.

The free estradiol index is a calculation based on estradiol and its carrier protein, SHBG. It isn't a direct measurement of free estradiol. These observational findings don't establish that raising estradiol prevents heart disease or that a particular urinary result predicts survival.

In men with type 2 diabetes, a higher blood estradiol-to-testosterone ratio has also been associated with fatty liver disease. A ratio can rise because estradiol rises, testosterone falls, or both. This research hasn't established an ideal hormone ratio to pursue, and combining urinary estradiol with blood testosterone doesn't reproduce the studied measurement.

Bone Loss Around Menopause

Estradiol helps limit bone breakdown. As ovarian estrogen production falls during the menopause transition, bone loss accelerates. In a study following 1,559 women, lower blood estradiol and higher FSH predicted the onset of bone loss at the spine and hip. FSH was the stronger predictor. FSH is a pituitary hormone involved in regulating ovarian function.

That study measured blood hormones. It doesn't establish a urinary estradiol threshold for bone loss or show that a falling urine result should determine when you have a bone density scan.

Brain Aging

Estrogen signaling in the brain changes across menopause. In an imaging study of 54 women, brain estrogen receptor availability was higher after menopause, and higher availability was associated with some memory and mood measures. This was a small, cross-sectional study of receptors, not a study showing that a particular estradiol level prevents dementia. Urinary estradiol hasn't been established as a predictor of cognitive decline.

Fertility and Early Pregnancy

Fertility care uses blood estradiol together with ultrasound and other clinical information. The meaning of the blood result depends on the treatment stage. In a retrospective study of 1,771 fresh IVF cycles, estradiol at the trigger injection was associated with pregnancy outcomes. A separate study of 26,194 hormone-supported frozen embryo transfer cycles associated higher estradiol before progesterone treatment with lower pregnancy and live birth rates. Other research found little association between estradiol around implantation and pregnancy outcomes.

These findings concern blood measurements during specific treatment protocols. They don't establish an equivalent interpretation for a full-day urine collection. Endometriosis also involves local estrogen production and altered estrogen breakdown within lesions, which helps explain why blood or urine estradiol alone cannot diagnose or exclude it.

When Results Can Be Misleading

  • Incomplete collection: missed urine, extra collection hours, or failure to mix the collection can distort the result. Because the value is divided by creatinine, a missed sample doesn't necessarily produce a predictably lower number.
  • Cycle timing: estradiol changes across the menstrual cycle. Collections from different phases can differ without indicating a change in health.
  • Creatinine and kidney function: muscle mass, creatinine excretion, and impaired kidney function can affect the reported ratio. A higher ratio can reflect changes in the denominator as well as changes in estradiol.
  • Hormone treatment: the product, dose, route, and dosing schedule affect estrogen metabolism and excretion. The result can include prescribed estradiol and cannot separate it from estradiol your body made.
  • Different estrogen products: synthetic estrogens and estrogen mixtures aren't all measured as estradiol. Their biological effects cannot be inferred from this result alone.
  • Pregnancy and blood contamination: pregnancy changes estrogen production, and menstrual or other blood in the sample can interfere with interpretation.
  • Analytical differences: sample preparation, release of estradiol from conjugates, calibration, and detection limits can differ across assays. Very low results may be near a method's reliable measuring limit. Results from different methods or collection types shouldn't be treated as a continuous personal trend.

What Moves This Biomarker

Evidence-backed interventions that affect your Estradiol (E2) level

↓ Decrease
Aromatase inhibitor treatment for hormone-sensitive breast cancer
Aromatase inhibitors reduce estrogen production. Early letrozole studies found substantial reductions in urinary estradiol, and randomized trials confirmed strong suppression of blood estradiol. These measurements differ from this creatinine-adjusted urine assay and don't establish a target for its result. Estrogen suppression benefits appropriately selected people with hormone-sensitive breast cancer, but treatment can cause bone loss and joint symptoms.
MedicationStrong Evidence
↑ Increase
Prescribed systemic estradiol therapy for menopausal symptoms
Estradiol treatment can raise urinary estradiol while relieving menopausal symptoms. A small observational study of women taking oral estradiol found higher excretion with higher doses, using a different mass-spectrometry method on 24-hour urine. Its measurements don't provide a dosing target for this assay. Whether treatment is beneficial depends on your symptoms, medical history, and treatment risks.
MedicationStrong Evidence
↑ Increase
Daily alcohol consumption equivalent to about two US standard drinks
In a randomized crossover study of 34 premenopausal women, daily alcohol over several menstrual cycles increased 24-hour urinary estradiol around ovulation and during the luteal phase. The study used an older antibody-based assay, so its numerical results cannot be applied directly to this LC-MS/MS result. Alcohol increases breast cancer risk through several mechanisms; your urine result doesn't quantify that risk.
LifestyleModerate Evidence

Frequently Asked Questions

Panels containing Estradiol (E2)

Estradiol (E2) is included in these pre-built panels.

References

43 studies
  1. Genova DiagnosticsLaboratory Sample Report
  2. Genova DiagnosticsSpecimen Collection Instructions2026
  3. Genova DiagnosticsLaboratory Preparation Guidance
  4. Genova DiagnosticsLaboratory Interpretation Guide
  5. Sally B. Coburn, Frank Z. Stanczyk, Roni T. Falk, Katherine a. Mcglynn, Louise a. Brinton, Joshua Sampson, Gary Bradwin, Xia Xu, Britton TrabertCancer Causes & Control2019

Estradiol (E2) Testing Option

Essential Estrogens (24-hour)

$415

An at-home 24-hour urine test that measures your estrogen levels and how your body breaks them down. Useful for understandinupg irregular cycles, fertility issues, menopause symptoms, and your hormone-related cancer risk profile.

Includes 10 biomarkers:
Estradiol (E2)Estrone (E1)Estriol (E3)2-OH(E1+E2)16α-OH E1
FSA/HSA eligible
No Rx needed
HIPAA compliant